These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11562518)

  • 21. Costs of non-small cell lung cancer in the Netherlands.
    van der Linden N; Bongers ML; Coupé VM; Smit EF; Groen HJ; Welling A; Schramel FM; Uyl-de Groot CA
    Lung Cancer; 2016 Jan; 91():79-88. PubMed ID: 26589654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost analysis of lung cancer management in South Western Sydney.
    Kang S; Koh ES; Vinod SK; Jalaludin B
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):235-41. PubMed ID: 22498199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of lung cancer: a methodological review.
    Molinier L; Combescure C; Chouaïd C; Daurès JP; Housset B; Fabre D; Grand A; Vergnenègre A
    Pharmacoeconomics; 2006; 24(7):651-9. PubMed ID: 16802841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs of care associated with non-small-cell lung cancer in a commercially insured cohort.
    Hillner BE; McDonald MK; Desch CE; Smith TJ; Penberthy LT; Maddox P; Retchin SM
    J Clin Oncol; 1998 Apr; 16(4):1420-4. PubMed ID: 9552046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model.
    Chouaid C; Bassinet L; Fuhrman C; Monnet I; Housset B
    J Clin Oncol; 1998 Aug; 16(8):2700-7. PubMed ID: 9704720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of a randomized clinical trial of hospital versus telephone follow-up after treatment for breast cancer.
    Beaver K; Hollingworth W; McDonald R; Dunn G; Tysver-Robinson D; Thomson L; Hindley AC; Susnerwala SS; Luker K
    Br J Surg; 2009 Dec; 96(12):1406-15. PubMed ID: 19918858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States.
    Schaefer CP; Cappelleri JC; Cheng R; Cole JC; Guenthner S; Fowler J; Johnson S; Mamolo C
    J Am Acad Dermatol; 2015 Oct; 73(4):585-593.e3. PubMed ID: 26253364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resource use and service costs for ventilator-dependent children and young people in the UK.
    Noyes J; Godfrey C; Beecham J
    Health Soc Care Community; 2006 Nov; 14(6):508-22. PubMed ID: 17059493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer.
    Banegas MP; Hassett MJ; Keast EM; Carroll NM; O'Keeffe-Rosetti M; Fishman PA; Uno H; Hornbrook MC; Ritzwoller DP
    Value Health; 2022 Jan; 25(1):69-76. PubMed ID: 35031101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
    Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
    Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective.
    Dumont S; Jacobs P; Fassbender K; Anderson D; Turcotte V; Harel F
    Palliat Med; 2009 Dec; 23(8):708-17. PubMed ID: 19837702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic analyses and lung cancer.
    Vergnenègre A; Molinier L; Chouaïd C
    Monaldi Arch Chest Dis; 2001 Aug; 56(4):336-43. PubMed ID: 11770217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD.
    Czech M; Opolski G; Zdrojewski T; Dubiel JS; Wizner B; Bolisęga D; Fedyk-Łukasik M; Grodzicki T
    Kardiol Pol; 2013; 71(3):224-32. PubMed ID: 23575775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimates of the lifetime costs of breast cancer treatment in Canada.
    Will BP; Berthelot JM; Le Petit C; Tomiak EM; Verma S; Evans WK
    Eur J Cancer; 2000 Apr; 36(6):724-35. PubMed ID: 10762744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare resource use and costs associated with renal impairment in US patients with bone metastases from solid tumors.
    Qian Y; Arellano J; Bhowmik D; Thomson E; Smith DM; Hechmati G; Song X
    J Oncol Pharm Pract; 2017 Apr; 23(3):195-202. PubMed ID: 26864940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting hospital costs in lung cancer patients in the United Kingdom.
    Kennedy MP; Hall PS; Callister ME
    Lung Cancer; 2016 Jul; 97():8-14. PubMed ID: 27237021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT
    Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer.
    Goodwin PJ; Feld R; Evans WK; Pater J
    J Clin Oncol; 1988 Oct; 6(10):1537-47. PubMed ID: 2845011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.